119 related articles for article (PubMed ID: 10400201)
21. A Novel Motion-on-Color Paradigm for Isolating Magnocellular Pathway Function in Preperimetric Glaucoma.
Wen W; Zhang P; Liu T; Zhang T; Gao J; Sun X; He S
Invest Ophthalmol Vis Sci; 2015 Jul; 56(8):4439-46. PubMed ID: 26193920
[TBL] [Abstract][Full Text] [Related]
22. Quantitative Analysis of the Displacement of the Anterior Visual Pathway by Pituitary Lesions and the Associated Visual Field Loss.
Boland MV; Lee IH; Zan E; Yousem DM; Miller NR
Invest Ophthalmol Vis Sci; 2016 Jul; 57(8):3576-80. PubMed ID: 27388050
[TBL] [Abstract][Full Text] [Related]
23. Multi-channel visual evoked potentials in early compressive lesions of the chiasm.
Flanagan JG; Harding GF
Doc Ophthalmol; 1988 Jul; 69(3):271-81. PubMed ID: 3168727
[TBL] [Abstract][Full Text] [Related]
24. Visual field defects in 23 acromegalic patients.
Kan E; Kan EK; Atmaca A; Atmaca H; Colak R
Int Ophthalmol; 2013 Oct; 33(5):521-5. PubMed ID: 23397103
[TBL] [Abstract][Full Text] [Related]
25. The clinical value of the multi-channel PVEP and PERG in the diagnosis and management of the patient with pituitary adenoma: a case report.
Lachowicz E; Lubiński W
Doc Ophthalmol; 2018 Aug; 137(1):37-45. PubMed ID: 29968203
[TBL] [Abstract][Full Text] [Related]
26. [Progressive, unilateral vision loss with changing nonspecific visual field findings. Chromophobic anterior pituitary adenoma].
Auffarth GU; Faller U; Krastel H; Göbel HH; Völcker HE
Ophthalmologe; 1997 Jul; 94(7):532-3. PubMed ID: 9333403
[No Abstract] [Full Text] [Related]
27. [Functional assessment before and after interventions on the optic chiasm system].
Menke E; Osarovsky E; Reitner A; Matula C
Wien Klin Wochenschr; 2002 Jan; 114(1-2):33-7. PubMed ID: 12407933
[TBL] [Abstract][Full Text] [Related]
28. Pituitary adenomas: automatic static perimetry and Goldmann perimetry. A comparative study of 345 visual field charts.
Grochowicki M; Vighetto A; Berquet S; Khalfallah Y; Sassolas G
Br J Ophthalmol; 1991 Apr; 75(4):219-21. PubMed ID: 2021588
[TBL] [Abstract][Full Text] [Related]
29. Predicting impairment of central vision from dimensions of the optic chiasm in patients with pituitary adenoma.
Carrim ZI; Reeks GA; Chohan AW; Dunn LT; Hadley DM
Acta Neurochir (Wien); 2007 Mar; 149(3):255-60; discussion 260. PubMed ID: 17273885
[TBL] [Abstract][Full Text] [Related]
30. Predictors for visual dysfunction in nonfunctioning pituitary adenomas - implications for neurosurgical management.
Schmalisch K; Milian M; Schimitzek T; Lagrèze WA; Honegger J
Clin Endocrinol (Oxf); 2012 Nov; 77(5):728-34. PubMed ID: 22747829
[TBL] [Abstract][Full Text] [Related]
31. [The clinical study of the damage of visual function caused by pituitary tumor].
Qi C; Li Q; Wang D; Dong L; Yang J; Li Q; Chen M
Yan Ke Xue Bao; 2008 Mar; 24(1):62-4. PubMed ID: 18709961
[TBL] [Abstract][Full Text] [Related]
32. The Application of a New Maximum Color Contrast Sensitivity Test to the Early Prediction of Chiasma Damage in Cases of Pituitary Adenoma: The Pilot Study.
Slatkeviciene G; Liutkeviciene R; Glebauskiene B; Zaliuniene D; Kriauciuniene L; Bernotas G; Tamasauskas A
Korean J Ophthalmol; 2016 Aug; 30(4):295-301. PubMed ID: 27478357
[TBL] [Abstract][Full Text] [Related]
33. Correlation of MRI Findings With Patterns of Visual Field Loss in Patients With Pituitary Tumors.
Kane EJ; Ashton DE; Mews PJ; Reid K; Neely A; Lueck CJ
J Neuroophthalmol; 2019 Sep; 39(3):333-338. PubMed ID: 30807381
[TBL] [Abstract][Full Text] [Related]
34. Retinotopic organization of the visual cortex before and after decompression of the optic chiasm in a patient with pituitary macroadenoma.
Chouinard PA; Striemer CL; Ryu WH; Sperandio I; Goodale MA; Nicolle DA; Rotenberg B; Duggal N
J Neurosurg; 2012 Aug; 117(2):218-24. PubMed ID: 22680245
[TBL] [Abstract][Full Text] [Related]
35. Recognition acuity, grating acuity, contrast sensitivity, and visual fields in 6-year-old children.
Hargadon DD; Wood J; Twelker JD; Harvey EM; Dobson V
Arch Ophthalmol; 2010 Jan; 128(1):70-4. PubMed ID: 20065220
[TBL] [Abstract][Full Text] [Related]
36. The pattern of visual impairment in patients with pituitary adenoma.
Wang H; Sun W; Fu Z; Si Z; Zhu Y; Zhai G; Zhao G; Xu S; Pang Q
J Int Med Res; 2008; 36(5):1064-9. PubMed ID: 18831902
[TBL] [Abstract][Full Text] [Related]
37. Visual prognostic value of optical coherence tomography and photopic negative response in chiasmal compression.
Moon CH; Hwang SC; Kim BT; Ohn YH; Park TK
Invest Ophthalmol Vis Sci; 2011 Oct; 52(11):8527-33. PubMed ID: 21960556
[TBL] [Abstract][Full Text] [Related]
38. The importance of the electrophysiological tests in the early diagnosis of ganglion cells and/or optic nerve dysfunction coexisting with pituitary adenoma: an overview.
Lachowicz E; Lubiński W
Doc Ophthalmol; 2018 Dec; 137(3):193-202. PubMed ID: 30374652
[TBL] [Abstract][Full Text] [Related]
39. Contrast Sensitivity in Eyes with Central Scotoma: Effect of Stimulus Drift.
Lewis P; Venkataraman AP; Lundström L
Optom Vis Sci; 2018 Apr; 95(4):354-361. PubMed ID: 29561506
[TBL] [Abstract][Full Text] [Related]
40. The Predictive Value of Suprasellar Extension for Visual Function Evaluation in Chinese Patients with Nonfunctioning Pituitary Adenoma with Optic Chiasm Compression.
Gan L; Ma J; Feng F; Wang Y; Cui J; Guo X; Zhang X; You H; Wang Z; Yin Z; Zhong Y; Xing B
World Neurosurg; 2018 Aug; 116():e960-e967. PubMed ID: 29857216
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
